Chlorthalidone

CAS 77-36-1 14 current records 11 historicalSmall Molecule

Who holds supplier records for Chlorthalidone? 14 organisations hold a current record for Chlorthalidone: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), Italy (1) and Spain (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Chlorthalidone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/chlorthalidone

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    12 of the 14 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Chlorthalidone expires 4 Sept 2045. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Chlorthalidone. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Chlorthalidone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Chlorthalidone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MSN LIFE SCIENCES PRIVATE LIMITED KamareddyIN
CEP 2024-505 - Rev 00
Chlortalidone, Form-I
Mar 2026—
MENADIONA, S.L. PalafollsES
CEP 2017-285 - Rev 02
Chlortalidone
Nov 2025Inspected May 2025
Spain
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2018-175 - Rev 03
Chlortalidone
Jun 2025—
MAITHRI DRUGS PRIVATE LIMITED Bonthapally VillageIN
CEP 2018-186 - Rev 02
Chlortalidone
Sept 2024Inspected Aug 2025
Sweden
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2012-004 - Rev 02
Chlortalidone, CT6 Process
May 2024—
CURIA ITALY S.R.L. OriggioIT
CEP 2001-020 - Rev 09
Chlortalidone, Milled; unmilled; micronised
Mar 2024Inspected Apr 2025
Italy
CTX LIFESCIENCES PVT. LIMITED SuratIN
R0-CEP 2021-392 - Rev 00
Chlortalidone
Jan 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (11)

Organisations whose Type II DMFs for Chlorthalidone are no longer active. These show a past filing, not current supply.

Show all 11 historical records
  • India · Inactive DMF 26648 · filed Nov 2012
  • A
    Inactive DMF 8204 · filed Aug 1989
  • Switzerland · Inactive DMF 6910 · filed Mar 1987
  • SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENT
    Inactive DMF 5109 · filed Sept 1983
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 5104 · filed Jul 1983
  • E MERCK
    Inactive DMF 5016 · filed Apr 1983
  • Finland · Inactive DMF 4682 · filed Oct 1982
  • Italy · Inactive DMF 4601 · filed Jun 1982
  • ACIC LTD
    Inactive DMF 3474 · filed Feb 1979
  • FARCHEMIA SRL
    Inactive DMF 3445 · filed Nov 1977
  • INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPA
    Inactive DMF 2814 · filed Dec 1976

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (36 listed products contain Chlorthalidone). The latest listed patent expires 4 Sept 2045. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Chlorthalidone is a thiazide-like diuretic used to treat hypertension and edema. It works by inhibiting sodium and chloride reabsorption in the distal convoluted tubules of the nephron, thereby increasing urine output and reducing blood volume.

Chemical identity

IUPAC name
2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide
Canonical SMILES
C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
InChIKey
JIVPVXMEBJLZRO-UHFFFAOYSA-N
Synonyms
Thalitone API, chlortalidone, chlortalidonum, clorpres component chlorthalidone, combipres component chlorthalidone, demi-regroton component chlorthalidone, g-33182, hemiclor, hygroton, kerledex component chlorthalidone, lopressidone component chlorthalidone, natriuran

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin 2 Receptor Blocker; Thiazide-like Diuretic
Mechanism of action
Angiotensin 2 Type 1 Receptor Antagonists
Physiologic effect
Decreased Blood Pressure; Increased Diuresis

Therapeutic areas

Cardiovascular DiseasesRenal Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Chlorthalidone?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Chlorthalidone: Ipca Laboratories Limited (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Ctx Lifesciences (India), CURIA ITALY SRL (Italy), MAITHRI DRUGS PRIVATE LTD (India), MENADIONA SL (Spain), MSN LIFE SCIENCES PRIVATE LIMITED (India) and AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Chlorthalidone Drug Master Files are active?

Ipca Laboratories Limited (DMF 27579, 17808), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 33071), Ctx Lifesciences (DMF 39142), CURIA ITALY SRL (DMF 2438), MAITHRI DRUGS PRIVATE LTD (DMF 32641), MENADIONA SL (DMF 34409), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 40515) and AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 30551) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Chlorthalidone records mean?

11 organisations have only inactive Type II DMFs for Chlorthalidone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Chlorthalidone have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Chlorthalidone on the EDQM register, including MSN LIFE SCIENCES PRIVATE LIMITED Kamareddy (IN), MENADIONA, S.L. Palafolls (ES), CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN), MAITHRI DRUGS PRIVATE LIMITED Bonthapally Village (IN), IPCA LABORATORIES LIMITED Mumbai (IN) and CURIA ITALY S.R.L. Origgio (IT) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Chlorthalidone?

Yes. The latest patent listed for an approved US product containing Chlorthalidone expires 4 Sept 2045, across 36 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Chlorthalidone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Chlorthalidone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.